These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 19341305)
1. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Maltseva T; Leveque VJ; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Kaiser AC; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 May; 52(9):2971-8. PubMed ID: 19341305 [TBL] [Abstract][Full Text] [Related]
2. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149 [TBL] [Abstract][Full Text] [Related]
4. Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication. Nilsson M; Kalayanov G; Winqvist A; Pinho P; Sund C; Zhou XX; Wähling H; Belfrage AK; Pelcman M; Agback T; Benckestock K; Wikström K; Boothee M; Lindqvist A; Rydegård C; Jonckers TH; Vandyck K; Raboisson P; Lin TI; Lachau-Durand S; de Kock H; Smith DB; Martin JA; Klumpp K; Simmen K; Vrang L; Terelius Y; Samuelsson B; Rosenquist S; Johansson NG Bioorg Med Chem Lett; 2012 May; 22(9):3265-8. PubMed ID: 22472694 [TBL] [Abstract][Full Text] [Related]
5. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989 [TBL] [Abstract][Full Text] [Related]
6. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups. Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479. Smith DB; Martin JA; Klumpp K; Baker SJ; Blomgren PA; Devos R; Granycome C; Hang J; Hobbs CJ; Jiang WR; Laxton C; Le Pogam S; Leveque V; Ma H; Maile G; Merrett JH; Pichota A; Sarma K; Smith M; Swallow S; Symons J; Vesey D; Najera I; Cammack N Bioorg Med Chem Lett; 2007 May; 17(9):2570-6. PubMed ID: 17317178 [TBL] [Abstract][Full Text] [Related]
8. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents. Oh CH; Kim E; Hong JH Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of novel acyclic nucleoside analogues of 5-(1-azido-2-haloethyl)uracils. Kumar R; Sharma N; Nath M; Saffran HA; Tyrrell DL J Med Chem; 2001 Nov; 44(24):4225-9. PubMed ID: 11708924 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro anti-HCV activity of beta-D- and 1-2'-deoxy-2'-fluororibonucleosides. Shi J; Du J; Ma T; Pankiewicz KW; Patterson SE; Hassan AE; Tharnish PM; McBrayer TR; Lostia S; Stuyver LJ; Watanabe KA; Chu CK; Schinazi RF; Otto MJ Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):875-9. PubMed ID: 16248053 [TBL] [Abstract][Full Text] [Related]
12. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus. Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system. Shi J; Du J; Ma T; Pankiewicz KW; Patterson SE; Tharnish PM; McBrayer TR; Stuyver LJ; Otto MJ; Chu CK; Schinazi RF; Watanabe KA Bioorg Med Chem; 2005 Mar; 13(5):1641-52. PubMed ID: 15698782 [TBL] [Abstract][Full Text] [Related]